The Xeloda market, driven by the chemotherapy drug capecitabine, plays a vital role in the global oncology therapeutics sector. Widely used in the treatment of colorectal, breast, and stomach cancers, Xeloda offers the advantage of oral administration, improving patient convenience and compliance compared to traditional intravenous chemotherapy. The market is evolving steadily due to rising...